Tonix Pharmaceuticals Holding Corp.

NASDAQ:TNXP

0.39 (USD) • At close December 24, 2024
Bedrijfsnaam Tonix Pharmaceuticals Holding Corp.
Symbool TNXP
Munteenheid USD
Prijs 0.385
Beurswaarde 72,010,258
Dividendpercentage 0%
52-weken bereik 0.12 - 14.08
Industrie Biotechnology
Sector Healthcare
CEO Dr. Seth Lederman M.D.
Website https://www.tonixpharma.com

An error occurred while fetching data.

Over Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address

Vergelijkbare Aandelen

Immunome, Inc. logo

Immunome, Inc.

IMNM

11.02 USD

X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.

XFOR

0.58 USD

Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc.

CABA

2.34 USD

Check-Cap Ltd. logo

Check-Cap Ltd.

CHEK

1.55 USD

Delcath Systems, Inc. logo

Delcath Systems, Inc.

DCTH

11.34 USD

Nutriband Inc. logo

Nutriband Inc.

NTRB

3.891 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)